Medicines Co. (MDCO) Tops Q1 EPS by 2c

April 25, 2018 7:08 AM EDT

Medicines Co. (NASDAQ: MDCO) reported Q1 EPS of ($0.76), $0.02 better than the analyst estimate of ($0.78). Revenue for the quarter came in at $7.77 million versus the consensus estimate of $7.99 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings